Faculty profile

Nora Wong

Back to faculty

LecturerDepartment of Human GeneticsMcGill University

Nora Wong

Lecturer

Department of Human Genetics

Faculty of Medicine and Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
7 publications in the last five years, latest in 2026.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

447

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their McGill University profile.

Latest papers

Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing after 60 Years of Age.
Annals of surgical oncology · 2026
ASO Visual Abstract: Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing After 60 Years of Age.
Annals of surgical oncology · 2026
Chemotherapy receipt in affected BRCA1/2 and PALB2 carriers with operable breast cancer: the impact of early detection and pre-diagnostic awareness on clinical outcomes and treatment.
Hereditary cancer in clinical practice · 2025

All 15 publications

15 publications.

Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing after 60 Years of Age.

Melanson A, Mashal S, Apostolova C, Ferroum A, Basik M, Boileau JF, Martel K, Meterissian S, Wong N, Weber E, Foulkes WD, Prakash I, Wong SM

Annals of surgical oncology20266 citations

DOI: 10.1245/s10434-025-18343-0 PMID: 40996624

ASO Visual Abstract: Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing After 60 Years of Age.

Melanson A, Mashal S, Apostolova C, Ferroum A, Basik M, Boileau JF, Martel K, Meterissian S, Wong N, Weber E, Foulkes WD, Prakash I, Wong SM

Annals of surgical oncology2026

DOI: 10.1245/s10434-025-18678-8 PMID: 41212459

Chemotherapy receipt in affected BRCA1/2 and PALB2 carriers with operable breast cancer: the impact of early detection and pre-diagnostic awareness on clinical outcomes and treatment.

Wong SM, Apostolova C, Ferroum A, Alhassan B, Prakash I, Basik M, Martel K, Meterissian S, Fleiszer D, Wong N, Sadinsky MB, Malagon T, Boileau JF, Foulkes WD

Hereditary cancer in clinical practice20252 citationsOpen Access

DOI: 10.1186/s13053-025-00314-x PMID: 40275390

Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy.

Apostolova C, Ferroum A, Alhassan B, Prakash I, Basik M, Boileau JF, Martel K, Meterissian S, Villareal Corpuz V, Wong N, Foulkes WD, Wong SM

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology202415 citationsOpen Access

DOI: 10.1016/j.ejso.2024.108324 PMID: 38636249

Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy.

Apostolova C, Ferroum A, Alhassan B, Prakash I, Viezel-Mathieu A, Basik M, Boileau JF, Meterissian S, Wong N, Foulkes WD, Wong SM

Annals of surgical oncology20246 citations

DOI: 10.1245/s10434-023-14418-y PMID: 37838650

Germline EGFR c.2527G > A (p.V843I) variant and familial lung cancer.

Alsaddah S, Papadakis AI, Wong N, Palma L, Szlachtycz D, Cruz Marino T, Fiset PO, Foulkes WD

Lung cancer (Amsterdam, Netherlands)20235 citations

DOI: 10.1016/j.lungcan.2023.107247 PMID: 37209596

Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?

Wong SM, Ferroum A, Apostolova C, Alhassan B, Prakash I, Basik M, Boileau JF, Meterissian S, Aleynikova O, Wong N, Foulkes WD

Annals of surgical oncology202222 citations

DOI: 10.1245/s10434-022-11916-3 PMID: 35616744

Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study

Lynn Macrae, Alícia Navarro de Souza, Carmen G. Loiselle, Nora W. Wong

Hereditary Cancer in Clinical Practice201310 citationsSenior authorOpen Access

DOI: 10.1186/1897-4287-11-14 PMID: 24131499

A survey of APC mutations in Quebec.

Jarry J, Brunet JS, Laframboise R, Drouin R, Latreille J, Richard C, Gekas J, Maranda B, Monczak Y, Wong N, Pouchet C, Zaor S, Kasprzak L, Palma L, Wu MK, Tischkowitz M, Foulkes WD, Chong G

Familial cancer201113 citations

DOI: 10.1007/s10689-011-9468-4 PMID: 21779980

Functional redundancy of exon 12 ofBRCA2revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant

Lili Li, Kajal Biswas, Laura Anne Habib, Sergey G. Kuznetsov, Nancy Hamel, Tomas Kirchhoff, Nora W. Wong, Susan Randall Armel, George Chong, Steven Alexander Narod, Kathleen Claes, Kenneth Offit, Mark E. Robson, Stacey Stauffer, Shyam K. Sharan, William David Foulkes

Human Mutation200937 citationsOpen Access

DOI: 10.1002/humu.21101 PMID: 19795481

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Nora Wong

Research

Latest papers

Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing after 60 Years of Age.

ASO Visual Abstract: Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing After 60 Years of Age.

Chemotherapy receipt in affected BRCA1/2 and PALB2 carriers with operable breast cancer: the impact of early detection and pre-diagnostic awareness on clinical outcomes and treatment.

Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy.

Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy.

Germline EGFR c.2527G > A (p.V843I) variant and familial lung cancer.

Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?

Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study

A survey of APC mutations in Quebec.

Functional redundancy of exon 12 ofBRCA2revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant

Frequent collaborators

William Foulkes

Sarkis Meterissian

Stephanie Wong

Mark Basik

Ipshita Prakash

George Chong

Evan Weber

Laura Palma

Steven Narod

Pierre Fiset

Yury Monczak

Talía Malagon

Carole Richard

ATILLA Omeroglu

Patricia Tonin

Carmen Loiselle

Nora Wong

Research

Latest papers

Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing after 60 Years of Age.

ASO Visual Abstract: Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing After 60 Years of Age.

Chemotherapy receipt in affected BRCA1/2 and PALB2 carriers with operable breast cancer: the impact of early detection and pre-diagnostic awareness on clinical outcomes and treatment.

Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy.

Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy.

Germline EGFR c.2527G&#xa0;>&#xa0;A (p.V843I) variant and familial lung cancer.

Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?

Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study

A survey of APC mutations in Quebec.

Functional redundancy of exon 12 ofBRCA2revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant

Frequent collaborators

William Foulkes

Sarkis Meterissian

Stephanie Wong

Mark Basik

Ipshita Prakash

George Chong

Evan Weber

Laura Palma

Steven Narod

Pierre Fiset

Yury Monczak

Talía Malagon

Carole Richard

ATILLA Omeroglu

Patricia Tonin

Carmen Loiselle

Germline EGFR c.2527G > A (p.V843I) variant and familial lung cancer.